BlackRock Advisors’s Perspective Therapeutics CATX Stock Holding History

BlackRock Advisors’s Portfolio CATX Stock Details CATX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	$9K	Hold	1,594	–	–	﹤0.01%	3577
2016 Q3	$11K	Hold	1,594	–	–	﹤0.01%	3562
2016 Q2	$14K	Hold	1,594	–	–	﹤0.01%	3518
2016 Q1	$14K	Hold	1,594	–	–	﹤0.01%	3514
2015 Q4	$15K	Hold	1,594	–	–	﹤0.01%	3557
2015 Q3	$22K	Hold	1,594	–	–	﹤0.01%	3491
2015 Q2	$24K	Buy	1,594 +588	+58%	+$9.53K	﹤0.01%	3455
2015 Q1	$16K	Hold	1,006	–	–	﹤0.01%	3479
2014 Q4	$15K	Buy	+1,006	New	+$15.9K	﹤0.01%	3560

Other funds holding CATX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

AFM

Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BCM

Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 17.11% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BlackRock Advisors's CATX Position: Q4 2016 in Review

BlackRock Advisors held its Perspective Therapeutics (CATX) position steady in Q4 2016 at 1,594 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #3577.

BlackRock Advisors first reported a position in CATX in Q4 2014 and has held it in 9 quarters since. The position peaked at $24K in Q2 2015. 30 funds tracked by Wall St. Rank hold CATX as of Q4 2016.

BlackRock Advisors held 1,594 shares of Perspective Therapeutics worth $9K as of Q4 2016.
BlackRock Advisors left its Perspective Therapeutics share count unchanged in Q4 2016.
Perspective Therapeutics made up ﹤0.01% of BlackRock Advisors's portfolio in Q4 2016, its #3577 holding.
BlackRock Advisors first reported a position in Perspective Therapeutics in Q4 2014 and has held it in 9 quarters since.
BlackRock Advisors's Perspective Therapeutics position peaked at $24K in Q2 2015.
30 funds tracked by Wall St. Rank held Perspective Therapeutics as of Q4 2016.

Based on BlackRock Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.